ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	16 December 2017
Main ID:	NCT00402623
Date of registration:	20/11/2006
Prospective Registration:	No
Primary sponsor:	Maastricht University Medical Center
Public title:	The Effect of Quercetin in Sarcoidosis
Scientific title:	The Effect of Quercetin on the Increased Inflammatory and Decreased Antioxidant Status in Sarcoidosis
Date of first enrolment:	January 2006
Target sample size:	18
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT00402623
Study type:	Interventional
Study design:	Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Phase:	N/A

Countries of recruitment
Netherlands

Contacts

Name:	Agnes W Boots, PhD
Address:
Telephone:
Email:
Affiliation:	Maastricht University

Name:	Guido R Haenen, PhD
Address:
Telephone:
Email:
Affiliation:	Maastricht University

Name:	Aalt Bast, PhD
Address:
Telephone:
Email:
Affiliation:	Maastricht University

Key inclusion & exclusion criteria

Inclusion Criteria:

- clinical diagnosis of sarcoidosis with emphasize on pulmonary sarcoidosis

- no smoking

- no treatment

Exclusion Criteria:

- clinical diagnosis (and treatment) of other diseases

- symptoms of sarcoidosis in other organs besides the lung

- use of food supplements or vitamins

Age minimum: N/A
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Sarcoidosis

Intervention(s)

Dietary Supplement: quercetin

Other: placebo

Primary Outcome(s)

inflammatory status after 24 hours [Time Frame: 24 hours]

antioxidant status after 24 hours [Time Frame: 24 hours]

Secondary Outcome(s)

plasma malondialdehyde (MDA) levels after 24 hours [Time Frame: 24 hours]

plasma quercetin concentration after 24 hours [Time Frame: 24 hours]

Secondary ID(s)

MEC 05.142.5

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

ZonMw: The Netherlands Organisation for Health Research and Development

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.